ÌÇÐÄvlog´«Ã½

UAE Neurology Devices Market Analysis

The UAE Neurology Devices Market is expected to register a CAGR of 8.30% during the forecast period.

The market studied is witnessing rapid growth, driven by a confluence of factors such as the rising incidence of neurological disorders, substantial investments in neurology devices by private enterprises, and a burgeoning elderly population.

The rise in neurological disorders, including brain aneurysms, brain tumors, and epilepsy, is a key driver of market growth. For instance, according to an article published by the Multidisciplinary Digital Publishing Institute (MDPI) in June 2022, a study conducted in the United Arab Emirates stated that a brain aneurysm is a critical condition that mostly affects young adults and may cause life-threatening complications such as brain hemorrhage. Thus, the significant burden of neurological diseases is expected to contribute to the growth of the market over the forecast period.

Furthermore, patients with untreated unruptured aneurysms have 50% excess long-term mortality compared with the general population, and one of the most innovative treatment options for brain aneurysms is the use of a flow-diverting stent (FDS). Thus, the high burden of diseases such as brain aneurysms and the increasing use of neurology devices such as FDS are expected to boost market growth. Moreover, according to an article published by PubMed Central in November 2022, brain and central nervous system cancer was among the most common forms of cancer in the United Arab Emirates. Thus, the high prevalence of such neurological disorders is expected to enhance the usage of neurological devices in the country and, therefore, propel market growth.

Moreover, strategic activities by market players, such as product launches and mergers and acquisitions, are expected to contribute to the market’s growth over the forecast period. For instance, in September 2022, Brain Navi strategically partnered with Medtreq Medical Equipment, a prominent distributor, to enhance the distribution network of its surgical navigation robot, NaoTrac, across the GCC region, with a specific focus on the United Arab Emirates. Such activities are likely to increase access to these devices and, therefore, boost market growth.

Thus, the increasing prevalence of neurological disorders, coupled with heightened research and development activities, is anticipated to drive market growth during the forecast period. However, the high cost of equipment is likely to impede this growth.

UAE Neurology Devices Industry Segmentation

Neurological devices are medical devices that help to diagnose, prevent, and treat a variety of neurological disorders and conditions, such as Alzheimer's disease, Parkinson's disease, major depression, and traumatic brain injury.

The UAE neurology devices market is segmented by type of device: cerebrospinal fluid management device, interventional neurology device, neurosurgery device, neurostimulation device, and other types of devices.

The report offers the value (USD) for the above segments.